Abstract
IntroductionMatrix metalloproteinases (MMP)-8 and -9 are regarded as biomarkers for periodontitis. The impact of head and neck carcinoma (HNC) radiotherapy (RT) on these biomarkers remains largely unexplored. This study aims to evaluate the impact of HNC RT on the proteases from host and bacteria, and their associations with the progression of periodontitis.MethodsTwenty-one patients with HNC receiving RT were included in this study. Mouthrinse samples were collected before RT (T0) and at the end of RT (T1). Periodontal examinations were conducted at T0 and one month after RT (T2). Samples were analyzed using a point-of-care kit for active (a) MMP-8, and ELISA for total (t) MMP-8, MMP-9, and interleukin (IL)-6 levels. Molecular forms of MMP-9 were assessed by gelatinolytic zymography. The activity levels of bacterial proteases, gingipain from Porphyromonas gingivalis and dentilisin from Treponema denticola, were assayed by using Fluorescence Resonance Energy Transfer (FRET) peptide substrates. Modified cumulative risk score (CRS) index was used for combinatory biomarker analysis. We evaluated the impact of RT on biomarker concentrations as well as their associations with the mean clinical attachment loss (CAL) development, categorized as either progressive (CAL ≥0.1 mm) or low/no progression (CAL <0.1 mm).ResultsAll patients suffered from periodontitis. There were significant increases in the levels of aMMP-8, tMMP-8, aMMP-9, as well as in four modified CRS-indices due to RT (P < 0.05), but no impact on the activities of gingipain (P = 0.365) or dentilisin (P = 0.620). The mean levels of aMMP-8 and tMMP-9 were associated with CAL progression (P = 0.044, P = 0.029, respectively).ConclusionHNC RT may result in the progression of periodontitis by increased activities of MMP-8 and -9. It seems that HNC RT has little impact on the activities of the bacteria-derived proteases dentilisin and gingipain.
| Original language | English |
|---|---|
| Article number | 10732748251351419 |
| Pages (from-to) | 1-11 |
| Number of pages | 11 |
| Journal | Cancer Control |
| Volume | 32 |
| Early online date | 22 Jun 2025 |
| DOIs | |
| Publication status | Published - Jul 2025 |
Funding
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was funded by the Helsinki and Uusimaa Hospital District (HUS), Finland (grant number TYH2020337, TYH2022225, Y2519SU010), the Finnish Dental Association Apollonia, Finland, and Karolinska Institutet, Sweden, and Finnish Dental Accociation (to E.B). Open access funding was provided by Helsinki University Library, University of Helsinki. This research did not received grants from any funding agency in the commercial sector. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
| Funders | Funder number |
|---|---|
| Helsingin Yliopisto | |
| Finnish Dental Accociation | |
| Karolinska Institutet | |
| Suomen Hammaslääkäriliitto | |
| Helsinki and Uusimaa Hospital District | TYH2022225, TYH2020337, Y2519SU010 |
Keywords
- biomarker
- head and neck carcinoma
- matrix metalloproteinase
- periodontitis
- radiotherapy
Fingerprint
Dive into the research topics of 'aMMP-8 and MMP-9: Potential Biomarkers for periodontitis Progression in Patients Receiving Radiotherapy for Head and Neck Carcinoma'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver